BIO Middle East Riyadh

BIO Middle East is an international trade exhibition and conference for the biotechnology, biopharmaceutical and life sciences sectors in the Middle East. Open exclusively to trade visitors, it provides a platform for collaboration between academia, industry, investors and other key stakeholders. The event focuses on innovative biotechnology developments and their financing, industrial application and commercialisation. It brings together international and regional companies, research institutions, start-ups, investors, healthcare professionals and policymakers, fostering connections across research, manufacturing and commercial markets.

BIO Middle East takes place at the Riyadh Exhibition & Convention Center in Malham, near Riyadh, Saudi Arabia. The event is organised by Informa PLC.

The exhibition covers a broad range of areas, including cell and gene therapies, vaccines and mRNA technologies, biopharmaceuticals and innovative therapeutics, biomanufacturing, genomics and proteomics, artificial intelligence and digital biotechnology, synthetic biology and clinical research. Other key areas include regulation, commercialisation and market access. Particular emphasis is placed on translating innovative technologies from research and development into clinical applications and industrial-scale manufacturing. Topics such as GMP-compliant manufacturing, CAR-T therapies, local vaccine production, technology transfer, supply chains and the use of artificial intelligence in drug development reflect the event’s strong focus on the practical and commercial implementation of biotechnology innovations.

The exhibition showcases products, technologies and services spanning the entire biotechnology value chain. These range from biopharmaceutical products and therapeutic platforms, vaccine and mRNA technologies, and cell and gene therapy solutions to laboratory equipment and manufacturing technologies. The event also features genomics and diagnostic technologies, as well as digital and AI-driven solutions for research and drug discovery. In addition, service providers cover contract development and manufacturing, clinical research, technology transfer, regulatory consulting and financing.

An integral part of BIO Middle East is its extensive conference and networking programme. Three stages – the Main Stage, Technical Stage and Innovation Pitches Stage – address the strategic, scientific, technical and commercial dimensions of biotechnology. The programme enables participants to keep abreast of the latest developments, establish new business contacts and connect with prospective collaboration and investment partners.

Exhibitors represent a wide cross-section of the life sciences industry, including biotechnology and biopharmaceutical companies, pharmaceutical manufacturers, vaccine and therapeutics developers, contract development and manufacturing organisations (CDMOs), biomanufacturing companies, and suppliers of laboratory, manufacturing and medical technologies. Research and clinical institutions, digital health and AI companies, consultancies and technology transfer organisations are also represented. The exhibitor profile is further complemented by start-ups, investors and other organisations involved in financing. The event therefore brings together international pharmaceutical and biotechnology companies, specialist technology providers and organisations from Saudi Arabia and other countries.

BIO Middle East is primarily aimed at professionals and senior decision-makers from biotechnology, pharmaceuticals, biopharmaceuticals, research, healthcare and the wider life sciences sector. Attendees include scientists and R&D executives, senior corporate leaders, business development and licensing professionals, procurement specialists, and experts in manufacturing and quality management. The event also attracts investors, venture capital firms, sovereign wealth funds, government officials and healthcare policymakers. It is particularly relevant to trade visitors seeking to evaluate or source new technologies, establish research and manufacturing partnerships, explore investment opportunities or prepare for market entry into Saudi Arabia and the wider Middle East.

The Riyadh Exhibition & Convention Center in Malham is located in the Greater Riyadh area and is designed to accommodate major international events. The venue is accessible by car, taxi, ride-hailing services and bus connections. Its proximity to Riyadh, Saudi Arabia’s political and economic centre, reinforces BIO Middle East’s role as a key interface between the international biotechnology industry and the country’s expanding life sciences sector.

The BIO Middle East will take place on 3 days from Monday, 14. December to Wednesday, 16. December 2026 in Riyadh.